DIAMMONIUM 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,17-NONACOSAFLUORO-2-HYDROXYHEPTADECYL PHOSPHATE
UNII D3F23WUE37

Substance Identification & Data

This profile provides standardized clinical and technical data for Diammonium 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,17-nonacosafluoro-2-hydroxyheptadecyl Phosphate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D3F23WUE37.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 94200-48-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D3F23WUE37

CAS Registry Number

94200-48-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DIAMMONIUM 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,17-NONACOSAFLUORO-2-HYDROXYHEPTADECYL PHOSPHATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H6F29O5P.2H4N

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ABXFOTMKHPEYQJ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

44153654

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(C(C(C(C(C(C(CC(COP(=O)([O-])[O-])O)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[NH4+].[NH4+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Diammonium 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,17-nonacosafluoro-2-hydroxyheptadecyl Phosphate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

1,2-HEPTADECANEDIOL, 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,17-NONACOSAFLUORO-,1-(DIHYDROGEN PHOSPHATE), DIAMMONIUM SALT

SYS

DIAMMONIUM 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,17-NONACOSAFLUORO-2-HYDROXYHEPTADECYL PHOSPHATE

SYS

DIAZANIUM (4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,17-NONACOSAFLUORO-2-HYDROXYHEPTADECYL) PHOSPHATE

SYS